What if a Pap test shows an abnormal result and an HPV test comes back positive at routine cervical cancer screening? These tests may indicate the presence of cancer, but often turn out to be a ‘false alarm’. Time-consuming examinations may then follow for further clarification, such as a colposcopy and, if tissue changes are seen, biopsy. If the outcome of the biopsy further points to abnormalities, surgical procedures are often performed, sometimes turning out to be done unnecessarily.
Cervical cancer – Reliable diagnosis with only one cervical smear
Oncgnostics GmbH developed the GynTect® test in order to prevent patients from this stressful period of uncertainty surrounding abnormal cervical cancer screening and follow-up results, and to offer doctors a quick and reliable cervical cancer diagnosis. This non-invasive test, performed from just one cervical smear, examines the DNA of cells for changes that indicate cervical cancer and its preliminary stages.
The innovation of the GynTect® test is the reliable detection of DNA methylation originally found in cervical carcinoma tissue, i.e. the alteration of the genetic material of abnormal cells. Thus, a cervical cancer diagnosis can be confirmed with certainty in a very short time or, in the case of supposedly positive Pap tests, the all-clear can be given. In previous studies, GynTect® reliably detected all cervical carcinomas, reason why the GynTect® test should be used in cervical cancer screening.